Can I appeal an EPO opposition decision?

Can I appeal an EPO opposition decison?
Can I appeal an EPO opposition decison?
ARTICLE SUMMARY

A decision of the EPO Opposition Division can be appealed by any party adversely affected, such as the patent proprietor, an opponent, or a valid intervenor. The appellant must file a notice of appeal and pay the fee within two months, submit the grounds within four months, after which the Board of Appeal conducts an independent review that may uphold, overturn, or remit the case.

authors
Authors
Related Services
Related Industries

A decision of the EPO Opposition Division (OD) can be appealed, but only by a party who took part in the opposition proceedings and is adversely affected by the decision.

Under Article 107 EPC, an appeal is restricted to “any party to proceedings adversely affected by a decision,” which means the patent proprietor, an opponent, or a valid intervenor (e.g., an assumed infringer who intervened under Article 105 EPC).  

To validly appeal, the adversely affected party must file a notice of appeal and pay the appeal fee within two months of notification of the written decision and must submit the statement of grounds of appeal within four months. The Board of Appeal will then conduct an independent judicial review of the OD’s decision, which may result in the decision being upheld, set aside, or the case being remitted back to the OD for further examination.

Related News

Kodak v FujiFilm: the Court of Appeal confirms UPC’s long-arm jurisdiction

Kodak v FujiFilm: the Court of Appeal confirms UPC’s long-arm jurisdiction

Comparing EPC Article 53(a) and US patent law in gene editing ethics

Comparing EPC Article 53(a) and US patent law in gene editing ethics

EPO Board of Appeal refers claim interpretation and added matter questions

EPO Board of Appeal refers claim interpretation and added matter questions

Creating an effective IP strategy for CAR-T

Creating an effective IP strategy for CAR-T

When is a synbio company a gene therapy company?

When is a synbio company a gene therapy company?

PCOS name changes to PMOS: Will PCOS’ name change impact patent applications

PCOS name changes to PMOS: Will PCOS’ name change impact patent applications

Drug repurposing in the age of AI: lessons from COVID-19 and the future of second medical use innovation

Drug repurposing in the age of AI: lessons from COVID-19 and the future of second medical use innovation

How to file an opposition at the European Patent Office (EPO)

How to file an opposition at the European Patent Office (EPO)

See All News
No items found.